Barrington Research Forecasts Strong Price Appreciation for Option Care Health (NASDAQ:OPCH) Stock

Option Care Health (NASDAQ:OPCH - Get Free Report) had its price objective lifted by equities research analysts at Barrington Research from $32.00 to $33.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Barrington Research's price target indicates a potential upside of 14.90% from the company's previous close.

OPCH has been the subject of a number of other reports. The Goldman Sachs Group lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and lowered their price objective for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Jefferies Financial Group downgraded shares of Option Care Health from a "buy" rating to a "hold" rating and lowered their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $26.00 to $33.00 in a research note on Monday. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Finally, JMP Securities restated a "market outperform" rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $29.86.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $1.00 on Tuesday, hitting $28.72. 4,027,509 shares of the company traded hands, compared to its average volume of 2,354,664. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63. The firm's 50-day simple moving average is $23.33 and its 200 day simple moving average is $27.70. The company has a market cap of $4.89 billion, a P/E ratio of 24.13, a P/E/G ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now directly owns 326,334 shares of the company's stock, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.64% of the company's stock.

Institutional Investors Weigh In On Option Care Health

Hedge funds have recently bought and sold shares of the business. UMB Bank n.a. lifted its position in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock valued at $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after buying an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after buying an additional 1,446 shares during the last quarter. International Assets Investment Management LLC increased its position in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after acquiring an additional 2,757 shares during the last quarter. Finally, Quarry LP lifted its holdings in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after acquiring an additional 2,628 shares during the period. Institutional investors own 98.05% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.